About the course
New trends in Biopharma besides mAb viz. ADC, Fusion Proteins and BsAbs
Charge heterogeneity is one of the key CQA need to be monitored
The cIEF-MS is the most appropriate technology to address the charge heterogeneity application challenge
The Agilent CE and MS coupled with EMASS-II CE-MS source provide seamless workflow for this application. This talk describes this approach and few examples